BUY UR-144 ONLINE
UR-144 has been manufactured and tested to meet ISO17025:2005 and Guide 34:2009 guidelines
- UR-144 has been manufactured and tested to meet ISO17025:2005 and Guide 34:2009 guidelines
- This product is intended to be used as an analytical reference standard
- Bulk material is available for academic research at qualified institutions; please contact our sales department for pricing
- KM-
X1
it is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their C of As and can be downloaded below using the batch number located on the product label. For a representative C of A please contact our technical support.
it is a synthetic cannabinoid which is derived from incense blends, and was originally developed by the American pharmaceuticals company, Abbott Laboratories.
Acting as a full agonist to the cannabinoid receptor CB2, it is closely related to substances such as A-796,260 and A-834,735, and is a useful chemical to have on board when undertaking studies into the affinity and competitive binding of comparable CB2 agonists.
Suitable for in vitro research purposes only, it is not sold for human consumption.
- UR-144 has been manufactured and tested to meet ISO17025:2005 and Guide 34:2009 guidelines
- This product is intended to be used as an analytical reference standard
- Bulk material is available for academic research at qualified institutions; please contact our sales department for pricing
- KM-
X1
it is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their C of As and can be downloaded below using the batch number located on the product label. For a representative C of A please contact our technical support.
it is a synthetic cannabinoid which is derived from incense blends, and was originally developed by the American pharmaceuticals company, Abbott Laboratories.
Acting as a full agonist to the cannabinoid receptor CB2, it is closely related to substances such as A-796,260 and A-834,735, and is a useful chemical to have on board when undertaking studies into the affinity and competitive binding of comparable CB2 agonists.
Suitable for in vitro research purposes only, it is not sold for human consumption